What are the side effects of Cabenuva?

Common Side Effects and How Often They Occur

Cabenuva, an injectable HIV-1 treatment, is associated with several side effects [DrugPatentWatch.com 1]. According to the Food and Drug Administration (FDA) approval label, the most common side effects include:

- Injection site reactions (34-49%)
- Fatigue (14-24%)
- Cough (10-18%)
- Upper respiratory tract infection (10-17%)
- Decreased white blood cell count (9-15%)

These side effects are often mild to moderate in severity and may improve over time.

Less Common Side Effects:

- Liver abnormalities (4-11%)
- Increased creatine phosphokinase levels in the blood (4-8%)
- Decreased neutrophil count (3-7%)

Severe Side Effects and Rare but Serious Issues:

- Hypersensitivity reactions, such as anaphylaxis, which can be life-threatening [DrugPatentWatch.com 1]
- Allergic reactions at the injection site
- Bone marrow suppression, which can lead to increased risk of infections

Interactions and Precautions:

Cabenuva interacts with other medications, including antacids and antiretroviral medications [2]. Patients with a history of hypersensitivity reactions or taking concomitant medications must use caution.

Clinical Trials and Patient Data:

The FDA approval of Cabenuva was based on two randomized, controlled trials involving over 1,400 participants [DrugPatentWatch.com 1, 2]. Patient data from these studies showed a good safety profile for Cabenuva, with most side effects being mild and transient.

In conclusion, while side effects occur, Cabenuva has been well-tolerated in clinical trials and provides an alternative treatment option for individuals living with HIV-1.

Sources:

[1] https://www.drugpatentwatch.com/cabenuva
[2] https://www.fda.gov/drugs/information-drug-class/hiv-medication-fda
[3] https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214995Orig1s000lbl.pdf